Advances in malignant melanoma
Advances in malignant melanoma
What involvement do stem cells have in disease and resistance?
How does the protein kinase Akt enable tumours to grow?
Using adoptive cell therapy to fight cancer
History and progress of CD38 in myeloma
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide
Drug combos with daratumumab likely to become standard of care in myeloma
New drugs and combinations in haematological cancers improve complete remission rates
CDK clinical trial results, benefit, side effects and costs
Extending indication of CDK 4/6 inhibitors in the adjuvant and neoadjuvant setting
Current indications for CDK 4/6 inhibitors (plus antiestrogen), biomarkers
Coming of age for CDK 4/6 inhibitors: Interactive session and close